VNTR allele frequencies show substantial ethnic variability, 9 suggesting that its observed LD with a putative 3 0 functional site may show similar variability among different ethnic populations from which ADHD triads were sampled.
Three independent reports of systematic mutation screens of the DAT gene did not locate any additional common coding variations that result in amino-acid substitutions, or promoter region variations modulating mRNA expression levels. [10] [11] [12] The gene exhibits a segmental pattern of LD, with a high but variable LD within 3 0 polymorphisms (exons 9-15), where two haplotype clades have been described, one of which segregates with the 10-repeat allele of the 3 0 VNTR and the other with the 9-repeat allele. 10 , 13 Greenwood et al 13 suggested the presence of a functional element in the 3 0 region of the gene, alternative variants of which may segregate with each of the clades and may contribute to various neuropsychiatric disorders. Similar to the above findings in ADHD, Greenwood et al 10 reported a trend for biased transmission of VNTR alleles among bipolar disorder triads, with a highly significant association for a haplotype composed of the 10-repeat allele and four 3 0 SNPs in the same sample. Taken together, these findings suggest that the use of haplotype mapping of the DAT1 3 0 region in association studies with ADHD as well as other neuropsychiatric disorders may be more informative, and may resolve some of the previous discrepancies in studies using the VNTR as a single marker. Another recently suggested source of variation may result from a gene environmental effect.
14 Further sequencing of this region and investigation of the functional significance of its variations are warranted. SIR-Trace amines are of interest in the study of neuropsychiatric disorders as they are found predominantly in the CNS, and altered levels have been observed in disorders such as schizophrenia, bipolar affective disorder, and anxiety disorders. 1 The genes 
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TRARs also share a high degree of sequence homology, and together form a subfamily of G protein-coupled receptors (GPCRs) that are related to serotonin-(5-HT-), dopamine-(DA-), and norepinephrine-(NE-) receptors. 1 To explore genetic variability at this locus, we established a PCR-based strategy to amplify the coding regions, and the 5 0 and 3 0 flanking regions of the TRARs, namely TRAR1, TRAR4, and TRAR5. We used this to sequence DNA from a representative sample of 96 individuals from the European population. 5 A total of 4467 bp of genomic DNA was screened, 3087 bp of which were exonic. Direct sequencing was performed as described elsewhere. 5 We identified 12 SNPs in the three TRARs which were submitted to dbSNP (http://www.ncbi.nlm.nih. gov/) under accession nos. ss125870000-ss12587012 (see Supplementary information).
Five SNPs were selected from the identified variants for genotyping in 118 parent -offspring triads with BPAD. These were selected on the basis of their functional aspects, and allele frequencies (nonsynonymous SNPs with minor allele frequencies 40.05, synonymous SNPs with minor allele frequencies 40.10). Positive association was observed in TRAR4, and we therefore analyzed the TRAR4 variants in an independent case-control replication sample consisting of 263 BPAD patients and 430 controls. All patients had been interviewed by experienced psychiatrists and psychologists using the Structured Clinical Interview for DSM-IV Disorders. 6 Lifetime 'best estimate' diagnoses according to DSM-IV criteria were established, based on multiple sources of information including personal structured interview (SCID I) and medical records. All participants were of German descent. Written informed consent was obtained from all patients and controls. Genotyping was carried out using RFLP assays (see Supplementary information). The transmission-disequilibriumtest (TDT) 7 was applied for the triad analysis. We used the Armitages trend test 8 for the case-control study and the FAMHAP 9 program for the haplotype analysis. Fisher's method 10 of the 'combination of probabilities from tests of significance' was used to determine the common significance of the casecontrol sample and the trio sample.
We analyzed rs8192620 in TRAR1, rs8192624 (V265I), rs8192625 (C291Y), and rs7772821 in TRAR4 and rs8192627 (D328A) in TRAR5 (Table 1 ). In the initial step, we genotyped all five SNPs in the triad sample and observed no significant TDT results in TRAR1 and TRAR5. In TRAR4, we observed a preferential transmission of the allele G of rs8192624 (P ¼ 0.014) to the affected child, and a trend toward association for rs8192625 (P ¼ 0.063) ( Table 1) . The results of the haplotype analysis did not strengthen our findings (data not shown). In the replication step, Genotype frequencies were in HWE for cases and controls.
Scientific Correspondence we analyzed the three TRAR4 variants in the casecontrol sample. Allele G of SNP rs8192624 again showed association with BPAD disease status (P ¼ 0.024), while the two other SNPs showed no association ( Table 1 ). The combined analysis of both samples with rs8192624 resulted in a significant association (P ¼ 0.004) ( Table 1 ). The combined analysis of rs8192624 for the two samples resulted in a significant association (P ¼ 0.004) ( Table 1) . After application of the Bonferroni correction for multiple testing, applied since five markers had been tested, the significance persists at alpha ¼ 0.05 (P ¼ 0.02). The result remains significant even when applying a further Bonferroni correction of 2 to account for the fact that a haplotype analysis was also conducted. rs8192624 is responsible for an amino-acid exchange (V265I) in the sixth transmembrane domain of the trace amine receptor 4 (predicted on the basis of seven transmembrane GPCR structures as depicted in the GPCR database (http://www.gpcr.org/)). However, no obvious functional sequelae are associated with this variant; valine and isoleucine are nonpolar neutral amino acids and valine in position 265 is not conserved in other species.
Our study provides evidence for the involvement of the TRAR4 locus in the etiology of BPAD. It is of interest to note that a recent study 11 has reported an association with SNPs at the 3 0 UTR of TRAR4 and schizophrenia. It could be speculated that genetic variation at this locus contributes to both disorders. However, given the differing locations of the associated SNPs within the gene, and the fact that Duan et al 11 did not observe association with rs8192624 and schizophrenia, there is currently no support for the hypothesis that a single variant contributes to both disorders. Independent replication studies in BPAD and schizophrenia using denser SNP maps are required to further define the role of TRAR4 in the etiology of psychiatric disorders.
Microarray results suggest altered transport and lowered synthesis of retinoic acid in schizophrenia A recent series of microarray expression analyses implicate entire pathways involving oxidative stress, energy metabolism and mitochondrial function in schizophrenia prefrontal cortex. 3 Dysregulation of the synthesis of RA, which mediates oxidative stress, regulates energy expenditure and influences mitochondrial functioning and apoptosis, 4 may exert a combined, cumulative influence on these pathways. Support for this suggestion can be deduced from examination of the microarray analyses referenced above: expression of the RA-synthesizing enzyme, aldehyde dehydrogenase 1A1 (ALDH1A1), a protein that is strongly expressed in dopaminergic neurons, 5 is significantly decreased; albumin, a ubiquitous serum transporter of RA 6 and other free fatty acids, for example, docosahexaenoic acid and arachidonic acid, which ligand the retinoid X receptors 7 is highly
